The TCL1 oncoprotein inhibits activation-induced cell death by impairing PKCθ and ERK pathways

Blood

Volumn 110, Issue 13, 2007, Pages 4406-4416

  Despouy, Gilles ^a,b   Joiner, Marjorie ^a,b   Le Toriellec, Emilie ^a,b   Weil, Robert ^c   Stern, Marc Henri ^a,b  

^a INSTITUT CURIE   (France)

^b INSTITUT CURIE   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; ONCOPROTEIN; PROTEIN KINASE C THETA; PROTEIN TCL1; UNCLASSIFIED DRUG; ISOENZYME; MTCP1 PROTEIN, HUMAN; PRKCQ PROTEIN, HUMAN; PROTEIN KINASE C; TCL1A PROTEIN, HUMAN;

ARTICLE; CELL ACTIVATION; CELL DEATH; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RNA INTERFERENCE; T LYMPHOCYTE; CELL CULTURE; CELL LINE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; LYMPHOCYTE ACTIVATION; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

CELL DEATH; CELL LINE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; ISOENZYMES; LYMPHOCYTE ACTIVATION; ONCOGENE PROTEINS; PHOSPHORYLATION; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 39649124274     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-11-059501     Document Type: Article

References (57)

1. Stern MH, Soulier J, Rosenzwajg M, et al. MTCP-1: a novel gene on the human chromosome Xq28 translocated to the T cell receptor alpha/delta locus in mature T cell proliferations. Oncogene. 1993;8:2475-2483.
2. Virgilio L, Narducci MG, Isobe M, et al. Identification of the TCL1 gene involved in T-cell malignancies. Proc Natl Acad Sci U S A. 1994;91:12530-12534.
3. Matutes E, Brito-Bapapulle V, Swansbury J, et al. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood. 1991;78:3269-3274.
4. Herling M, Khoury JD, Washington LT, Duvic M, Keating MJ, Jones D. A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories. Blood. 2004;104:328-335.
5. MTCP1 is restricted to mature T-cell proliferations with t(X;14) translocations. Blood. 1996;87:1923-1927.
6. Teitell MA. The TCL1 family of oncoproteins: coactivators of transformation. Nat Rev Cancer. 2005;5:640-648.
7. Gritti C, Dastot H, Soulier J, et al. Transgenic mice for MTCP1 develop T-cell prolymphocytic leukemia. Blood. 1998;92:368-373.
8. Virgilio L, Lazzeri C, Bichi R, et al. Deregulated expression of TCL1 causes T cell leukemia in mice. Proc Natl Acad Sci U S A. 1998;95:3885-3889.
9. Hoyer KK, French SW, Turner DE, et al. Dysregulated TCL1 promotes multiple classes of mature B cell lymphoma. Proc Natl Acad Sci U S A. 2002;99:14392-14397.
10. Fu TB, Virgilio L, Narducci MG, Facchiano A, Russo G, Croce CM. Characterization and localization of the TCL-1 oncogene product. Cancer Res. 1994;54:6297-6301.
11. Pekarsky Y, Hallas C, Isobe M, Russo G, Croce CM. Abnormalities at 14q32.1 in T cell malignancies involve two oncogenes. Proc Natl Acad Sci U S A. 1999;96:2949-2951.
12. 13MTCP1. J Biomol NMR 1998;11:339-356.
13. 14TCL1, an oncogene product involved in T-cell prolymphocytic leukemia, reveals a novel β-barrel topology. Structure. 1998;6:147-155.
14. Laine J, Kunstel G, Obata T, Sha M, Noguchi M. The protooncogene TCL1 is an Akt kinase coactivator. Molecular Cell. 2000;6:395-407.
15. Pekarsky Y, Koval A, Hallas C, et al. Tcl1 enhances Akt kinase activity and mediates its nuclear translocation. Proc Natl Acad Sci U S A. 2000;97:3028-3033.
16. Kunstle G, Laine J, Pierron G, et al. Identification of Akt association and oligomerization domains of the Akt kinase coactivator TCL1. Mol Cell Biol. 2002;22:1513-1525.
17. Auguin D, Barthe P, Royer C, et al. Structural basis for the co-activation of protein kinase B by Tcell leukemia-1 (TCL1) family proto-oncoproteins. J Biol Chem. 2004;279:35890-35902.
18. French SW, Shen RR, Koh PJ, Malone CS, Mallick P, Teitell MA. A modeled hydrophobic domain on the TCL1 oncoprotein mediates association with AKT at the cytoplasmic membrane. Biochemistry. 2002;41:6376-6382.
19. Noguchi M, Ropars V, Roumestand C, Suizu F. Proto-oncogene TCL1: more than just as a coactivator for Akt. Faseb J. 2007; 21:2273-2284.
20. Herling M, Teitell MA, Shen RR, Medeiros LJ, Jones D. TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin. Blood. 2003;101:5007-5009.
21. Kang SM, Narducci MG, Lazzeri C, et al. Impaired T- and B-cell development in Tcl1-deficient mice. Blood. 2005;105:1288-1294.
22. Shen RR, Ferguson DO, Renard M, et al. Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation. Blood. 2006;108:1991-1998.
23. Li QS, Tanaka S, Kisenge RR, Toyoda H, Azuma E, Komada Y. Activation-induced T cell death occurs at G1A phase of the cell cycle. Eur J Immunol. 2000;30:3329-3337.
24. Green DR, Droin N, Pinkoski M. Activation-induced cell death in T cells. Immunol Rev. 2003;193:70-81.
25. Chwae YJ, Chang MJ, Park SM, et al. Molecular mechanism of the activation-induced cell death inhibition mediated by a p70 inhibitory killer cell Ig-like receptor in Jurkat T cells. J Immunol. 2002;169:3726-3735.
26. Villalba M, Kasibhatla S, Genestier L, Mahboubi A, Green DR, Altman A. Protein kinase C theta cooperates with calcineurin to induce Fas ligand expression during activation-induced T cell death. J Immunol. 1999;163:5813-5819.
27. Ghaffari-Tabrizi N, Bauer B, Villunger A, et al. Protein kinase C theta, a selective upstream regulator of JNK/SAPK and IL-2 promoter activation in Jurkat T cells. Eur J Immunol. 1999;29:132-142.
28. Manicassamy S, Sun Z. The critical role of protein kinase C-theta in Fas/Fas ligand-mediated apoptosis. J Immunol. 2007;178:312-319.
29. Baier G. The PKC gene module: molecular biosystematics to resolve its T cell functions. Immunol Rev. 2003;192:64-79.
30. Sedwick CE, Altman A. Perspectives on PKCtheta in T cell activation. Mol Immunol. 2004;41:675-686.
31. Sun Z, Arendt CW, Ellmeier W, et al. PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes. Nature. 2000;404:402-407.
32. Pfeifhofer C, Kofler K, Gruber T, et al. Protein kinase C theta affects Ca2+ mobilization and NFAT cell activation in primary mouse T cells. J Exp Med. 2003;197:1525-1535.
33. Barouch-Bentov R, Lemmens EE, Hu J, et al. Protein kinase C-theta is an early survival factor required for differentiation of effector CD8+ T cells. J Immunol. 2005;175:5126-5134.
34. Sparatore B, Passalacqua M, Pedrazzi M, et al. Role of the kinase activation loop on protein kinase C theta activity and intracellular localisation. FEBS Lett. 2003;554:35-40.
35. Lee KY, D'Acquisto F, Hayden MS, Shim JH, Ghosh S. PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation. Science. 2005;308:114-118.
36. Teitell M, Damore MA, Sulur GG, et al. TCL1 oncogene expression in AIDS-related lymphomas and lymphoid tissues. Proc Natl Acad Sci U S A. 1999;96:9809-9814.
37. Smith SD, McFall P, Morgan R, et al. Long-term growth of malignant thymocytes in vitro. Blood. 1989;73:2182-2187.
38. Weil R, Sirma H, Giannini C, et al. Direct association and nuclear import of the hepatitis B virus X protein with the NF-kappaB inhibitor IkappaBalpha. Mol Cell Biol. 1999;19:6345-6354.
39. van de Wetering M, Oving I, Muncan V, et al. Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep. 2003;4:609-615.
40. Sirven A, Ravet E, Charneau P, et al. Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors. Mol Ther. 2001;3:438-448.
41. National Center for Biotechnology Information. BLAST: Basic Local Alignment and Search Tool. http://0-www.ncbi.nlm.nih.gov.catalog.llu.edu/BLAST/. Accessed .
42. Ravet E, Reynaud D, Titeux M, et al. Characterization of DNA-binding-dependent and -independent functions of SCL/TAL1 during human erythropoiesis. Blood. 2004;103:3326-3335.
43. de la Grange PB, Armstrong F, Duval V, et al. Low SCL/TAL1 expression reveals its major role in adult hematopoietic myeloid progenitors and stem cells. Blood. 2006;108:2998-3004.
44. Wyllie AH, Morris RG, Smith AL, Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol. 1984;142:67-77.
45. Shi YF, Bissonnette RP, Parfrey N, Szalay M, Kubo RT, Green DR. In vivo administration of monoclonal antibodies to the CD3 T cell receptor complex induces cell death (apoptosis) in immature thymocytes. J Immunol. 1991;146:3340-3346.
46. Altman A, Isakov N, Baier G. Protein kinase Ctheta: a new essential superstar on the T-cell stage. Immunol Today. 2000;21:567-573.
47. van den Brink MR, Kapeller R, Pratt JC, Chang JH, Burakoff SJ. The extracellular signal-regulated kinase pathway is required for activation-induced cell death of T cells. J Biol Chem. 1999;274:11178-11185.
48. Zhu L, Yu X, Akatsuka Y, Cooper JA, Anasetti C. Role of mitogen-activated protein kinases in activation-induced apoptosis of T cells. Immunology. 1999;97:26-35.
49. Xi H, Kersh GJ. Induction of the early growth response gene 1 promoter by TCR agonists and partial agonists: ligand potency is related to sustained phosphorylation of extracellular signal-related kinase substrates. J Immunol. 2003;170:315-324.
50. Puente LG, He JS, Ostergaard HL. A novel PKC regulates ERK activation and degranulation of cytotoxic T lymphocytes: plasticity in PKC regulation of ERK. Eur J Immunol. 2006;36:1009-1018.
51. Puente LG, Stone JC, Ostergaard HL. Evidence for protein kinase C-dependent and -independent activation of mitogen-activated protein kinase in T cells: potential role of additional diacylglycerol binding proteins. J Immunol. 2000;165:6865-6871.
52. Hoyer KK, Herling M, Bagrintseva K, et al. T cell leukemia-1 modulates TCR signal strength and IFN-γ- levels through phosphatidylinositol 3-kinase and protein kinase C pathway activation. J Immunol. 2005;175:864-873.
53. Hayashi K, Altman A. Protein kinase C theta (PKCtheta): a key player in T cell life and death. Pharmacol Res. 2007;55:537-544.
54. Dudley E, Hornung F, Zheng L, Scherer D, Ballard D, Lenardo M. NF-kappaB regulates Fas/APO-1/CD95- and TCR-mediated apoptosis of T lymphocytes. Eur J Immunol. 1999;29:878-886.
55. Standaert ML, Bandyopadhyay G, Sajan MP, Cong L, Quon MJ, Farese RV. Okadaic acid activates atypical protein kinase C (zeta/lambda) in rat and 3T3/L1 adipocytes: an apparent requirement for activation of Glut4 translocation and glucose transport. J Biol Chem. 1999;274:14074-14078.
56. Hansra G, Bornancin F, Whelan R, Hemmings BA, Parker PJ. 12-O-Tetradecanoylphorbol-13-acetate-induced dephosphorylation of protein kinase Calpha correlates with the presence of a membrane-associated protein phosphatase 2A heterotrimer. J Biol Chem. 1996;271:32785-32788.
57. Lenardo M, Chan KM, Hornung F, et al. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol. 1999;17:221-253.